Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ora Secunda Cerclage Laser Retinopexy To Prevent Retinal Detachment In Stickler Syndrome (OSC/SS): A Prospective Historically Controlled Study

NCT07146516 is registered in ClinicalTrials.gov with Helen Keller Eye Research Foundation as lead sponsor.

NCT NCT07146516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07146516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ora Secunda Cerclage Laser Retinopexy To Prevent Retinal Detachment In Stickler Syndrome (OSC/SS): A Prospective Historically Controlled Study
Lead sponsor
Helen Keller Eye Research Foundation
Phase
Not applicable
Overall status
Recruiting
Start date
October 30, 2025
Completion date
December 31, 2035
Enrollment
500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stickler syndrome type 1, stickler syndrome type 2